Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Alkido Pharma Inc. (AIKI)

0.8772   -0.101 (-10.33%) 08-13 16:00
Open: 0.9698 Pre. Close: 0.9782
High: 0.97 Low: 0.8745
Volume: 2,884,239 Market Cap: 31M
AIkido Pharma Inc., a biotechnology development company, focuses on developing small-molecule anti-cancer therapeutics. The company engages in the development of therapeutic drugs for the treatment of pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). Its portfolio includes KPC-34 for the treatment of AML and ALL; and DHA-dFdC drug for the treatment of pancreatic cancer. AIkido Pharma Inc. has an artificial intelligence and machine learning research agreement with Cogia Biotech LTD. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2020. AIkido Pharma Inc. was founded in 1967 and is based in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.971 - 0.979 0.979 - 0.984
Low: 0.855 - 0.863 0.863 - 0.868
Close: 0.869 - 0.882 0.882 - 0.89

Technical analysis

as of: 2020-08-13 4:31:23 PM
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 1.36     One year: 1.62
Support: Support1: 0.80    Support2: 0.67
Resistance: Resistance1: 1.16    Resistance2: 1.39
Pivot: 1.11
Moving Average: MA(5): 1.06     MA(20): 1.12
MA(100): 0.82     MA(250): 1.21
MACD: MACD(12,26): 0.03     Signal(9): 0.06
Stochastic oscillator: %K(14,3): 8.99     %D(3): 27.48
RSI: RSI(14): 39.06
52-week: High: 2.74  Low: 0.48  Change(%): -58.1
Average Vol(K): 3-Month: 469850  10-Days: 316271

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
AIKI has closed below the lower band by 18.6%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 20.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 11 Aug 2020
AIkido Pharma Inc. Extends Option Agreement; The Fundamental Debate on (AIKI) -

Fri, 07 Aug 2020
Bulls Are Starting To Focus In On AIkido Pharma Inc. (AIKI) - Invest Million

Fri, 07 Aug 2020
AIkido Pharma Inc. (AIKI) is on the roll with an average volume of 4.53M in the recent 3 months - The InvestChronicle

Tue, 28 Jul 2020
Is Aikido Pharma Inc (AIKI) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver

Fri, 24 Jul 2020
Is Aikido Pharma Inc (AIKI) a Stock to Watch This Week? - InvestorsObserver

Thu, 23 Jul 2020
AIkido Pharma Inc. (AIKI) Quarterly Performance is 44.23%: Here is the Surprise Factor - The InvestChronicle

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqCM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 35
Shares Float (M) 27
% Held by Insiders 5.64
% Held by Institutions 17.45
Shares Short (K) 114
Shares Short P. Month (K) 42

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin -81900.00
Return on Assets (ttm) -27.5
Return on Equity (ttm) -71.2
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -4
Levered Free Cash Flow (M) -6

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 3403.53
Price to Cash Flow -8.58

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 1980-05-11
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.